Bone Marrow TransplantationBone NeoplasmsBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesTransplantation, AutologousWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningTissue DonorsGraft SurvivalTransplantation ChimeraHematopoietic Stem CellsHistocompatibility TestingBone Marrow PurgingHistocompatibilityBusulfanBone Marrow DiseasesImmunosuppressive AgentsBone Marrow ExaminationBone RemodelingTransplantation, IsogeneicHematopoiesisCyclophosphamideKidney TransplantationHematologic NeoplasmsLeukemia, Myeloid, AcuteMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecurrenceRadiation ChimeraCytomegalovirus InfectionsBone Marrow NeoplasmsGraft RejectionLiver TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsImmunosuppressionTreatment OutcomeCombined Modality TherapyAcute DiseaseGraft vs Host ReactionLymphocyte DepletionHepatic Veno-Occlusive DiseaseCyclosporineRemission InductionBone DensityLeukemia, MyeloidRetrospective StudiesHLA AntigensColony-Forming Units AssayT-LymphocytesSurvival AnalysisHematologic DiseasesLymphoma, Non-HodgkinMyelodysplastic SyndromesLeukocyte TransfusionOpportunistic InfectionsNuclear FamilyLymphocyte TransfusionImmunocompromised HostChimeraTransplantation ImmunologyBone ResorptionStem Cell TransplantationSevere Combined ImmunodeficiencyFatal OutcomeHeart TransplantationCell DifferentiationActuarial AnalysisLeukocyte CountSurvival RateSpleenFollow-Up StudiesMice, Inbred BALB CFlow CytometryGraft vs Tumor EffectDisease-Free SurvivalAntineoplastic Combined Chemotherapy ProtocolsLung TransplantationAntilymphocyte SerumCells, CulturedMultiple MyelomaPancytopeniaGranulocyte Colony-Stimulating FactorAntigens, CD34CytomegalovirusInfectionBlood Group IncompatibilityGraft vs Leukemia EffectMycosesPneumonia, ViralGranulocytesHodgkin DiseaseMice, KnockoutPolymerase Chain Reaction